BioMérieux to Acquire BioFire Diagnostics for $450M Plus Debt | GenomeWeb

NEW YORK (GenomeWeb News) — French in vitro diagnostics firm BioMérieux said today that it has entered into an agreement to acquire BioFire Diagnostics for $450 million plus BioFire's net financial debt.

BioFire, which until August 2012 was known as Idaho Technology, is based in Salt Lake City, Utah, and markets the FilmArray molecular diagnostics system and associated syndromic infectious disease assay panels.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.